The Heart/X
Jul 14, 2025, 12:30
The Heart: Managing Warfarin-Induced Coagulopathy – New Insights into Handling Prolonged INR Levels
The Heart has published on its official X page:
“Management of Prolonged INR (Warfarin-Induced Coagulopathy)”
Effective management of warfarin-induced coagulopathy, characterized by prolonged INR, is crucial to mitigate bleeding risks. Recent updates highlight evidence-based strategies for timely INR reversal, emphasizing a balance between anticoagulation control and patient safety.
More detailed insights on this topic are available at Hemostasis Today.
American Society of Hematology
American Thrombosis and Hemostasis Network
Anticoagulant complications
Bleeding risk reduction
Coagulopathy guidelines
EHA
Emergency anticoagulation care
Hemostasis and Thrombosis Research Society
Hemostasis management
Hemostasis Today
INR reversal strategies
Prolonged INR management
The Heart
Vitamin K antagonists
Warfarin safety
Warfarin-induced coagulopathy
World Federation of Hemophilia
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
-
Jan 22, 2026, 11:28Abdulrahman Katib on API-CAT Trial’s Evaluation of Apixaban Dosing
-
Jan 22, 2026, 11:19Bruno Odisio: Ablation Margins Are Software-Dependent
-
Jan 22, 2026, 10:38Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
-
Jan 22, 2026, 10:29Marvin Garcia Reyes Presents a Case of Aorto-Visceral and Aorto-Iliac Thrombosis